News
16hon MSN
100 days into the job, FDA head talks to CNN about agency goals— and Coke’s switch to sugar
Commissioner Marty Makary says the FDA will plow ahead with big plans on ultra process foods, dietary guidelines and ...
18don MSN
FDA Layoffs Could Compromise Safety of Medications Made at Foreign Factories, Inspectors Say
For years, inspectors have uncovered dirty equipment, contaminated supplies and fraudulent testing records in some overseas factories — serious safety and quality breaches that can sicken or kill ...
George Tidmarsh appointed to lead FDA drug review division amid staffing cuts and scrutiny over accelerated approvals and ...
Makary said that the staffing cuts primarily involved 2,600 HR, contract, and budget staff, and only about 1,900 were involved in the reduction-in-force, with another 1,200 taking early retirement.
WASHINGTON — The steady erosion of experienced staff at the Food and Drug Administration is slowly compromising the agency’s ...
Following FDA cuts, ... But he also hinted that current staffing levels may not be maintained because of a large expansion in FDA staff, which now number around 19,000.
FDA staff cuts are already impacting regulatory work, Biotech leaders warn. Apr. 10, 2025 11:37 AM ET Pfizer Inc. (PFE) Stock, BEAM Stock, RNA Stock, ARQT Stock TVTX, XFOR, APLS, STRO, NKTX, PEPG ...
The Trump administration’s proposed cuts to medical research and health agencies will curtail the development of promising ...
Tidmarsh, who has founded and served as CEO of several biotech companies, will lead a crucial FDA division that reviews the ...
In FDA job cuts, experts see threat ... Kenneth Kaitin, a professor and senior fellow at Tufts University School of Medicine, noted the potential impact on FDA staff’s experience in the future.
Potential NIH and FDA cuts could lower the number of new drugs that come to market in the next three decades, according to a CBO analysis.
CBS Chicago on MSN1d
FDA's AI tool cites nonexistent study
The Trump administration has touted AI as a way to cut government staffing, but the FDA's new AI tool has been citing nonexistent studies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results